Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa®), in antiretroviral-naïve patients: A 48-week, multicentre, randomized study (Lake Study)

1. Echeverría, P.
2. Negredo, E.
3. Carosi, G.
4. Gálvez, J.
5. Gómez, J.L.
6. Ocampo, A.
7. Portilla, J.
8. Prieto, A.
9. López, J.C.
10. Rubio, R.
11. Mariño, A.
12. Pedrol, E.
13. Viladés, C.
14. del Arco, A.
15. Moreno, A.
16. Bravo, I.
17. López-Blazquez, R.
18. Pérez-Alvarez, N.
19. Clotet, B.